Sino-U.S. Investment Vehicle To Bring U.S. Medicines Into Chinese Pharmaceutical Market

In the U.S. the pharmaceutical industry has proprietary technology, but China has enough financial resources and a huge domestic market. Therefore an opportunity presents itself for those who can bridge these two markets. Michelle Jarboe McFee has an interesting article about a partnership between Newsummit Pharmaceutical Group, a biomedical company in Shanghai and Cleveland Bio […]

IP Specialist Xiang Wang Transfers From Jones Day to Orrick

Dr. Xiang Wang, formerly co-head of Jones Day’s Mainland China IP practice, will lead Orrick, Herrington & Sutcliffe LLP’s China IP practice at their Beijing Office. Read more here.